Events
Register and find information for upcoming events from BioSpace and partners.
Interested in publishing your upcoming event on BioSpace? Submit events here.
Interested in putting on your own event? Talk to us.
Upcoming Events
FDA’s draft guidance on the validation of non-animal methods (NAMs) is reshaping how nonclinical programs are designed and justified. This webinar explores how sponsors can apply NAMs to streamline development, improve human relevance, and support IND decision-making within a weight-of-evidence framework.
Wednesday, July 1, 2026 10–11am EDT
·
Virtual
This webinar provides an assessment of recent job market activity across biopharma and explores how companies approaching commercial readiness or building out sales and marketing teams can navigate today’s hiring trends.
Wednesday, July 22, 2026 2–3pm EDT
·
Virtual
Drug discovery teams have more data than ever, but turning that data into actionable insight remains a major challenge. In this candid conversation, Patsnap’s Ben Coverdale is joined by Mark Davies, Head of Product for Life Sciences, and James Longden, Senior Director, Life Sciences at Evolvus to explore how AI-powered intelligence is reshaping candidate optimization across antibodies, ADCs, and peptides.
Tuesday, July 28, 2026 10–11am EDT
·
Virtual
The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
June 22, 2026 - June 25, 2026
·
San Diego, California
Join this panel to hear leaders from Merck, Orum, Xyone, and leading Chinese biotechs MediLink and Lepu for a China–West dialogue on ADC innovation and globalization. The panel will explore where China and the West may diverge in ADC development, how manufacturing and supply chain could shape the next competitive edge, the path from China innovation to global products, and where the next wave of ADC breakthroughs may come from. Wednesday, July 1, 2026 · 11:00 AM ET · Virtual
Wednesday, July 1, 2026 11am EDT
·
Virtual
Catalysis 2026 conference will serve as a multidisciplinary platform to discuss novel materials and reaction systems, advanced catalytic mechanisms, reactor design, and computational approaches that are driving transformative progress in catalysis. Topics of focus will include but are not limited to: 1. Homogeneous and heterogeneous catalysis 2. Biocatalysis and enzyme engineering 3. Photocatalysis and electrocatalysis 4. Nanocatalysts and advanced catalyst materials 5. Process intensification and green chemistry 6. Catalysis for energy, fuels, and environmental applications 7. Industrial catalysis and scale-up challenges
Wednesday, July 8, 2026 9am–5pm CDT
·
Singapore, Singapore
Work with the BioSpace Insights team to engage decision-makers through thoughtful and impactful content.
Past Events
Biotech has been pulling off some remarkable science of late, while M&A and IPOs return to bolster the sector. But that doesn’t mean the industry is back from the brink. BioSpace gathered three early-stage biotech CEOs and members of the NextGen Class of 2026 to talk about surviving and thriving in this rollercoaster market, all while bringing forward the next generation of medicines.
More Past Events
Taking an early proof of concept into preclinical and clinical development is a costly and complex process. But there are strategic ways to streamline the process and reduce risk and costs. In this webinar, you’ll hear directly from Nobel Laureate Sir Michael Houghton and experts from Applied Pharma, who bring decades of real-world success and deep scientific expertise.
This webinar provides a clear-eyed assessment of current hiring conditions across biopharma, exploring which roles and skills are in demand, where opportunities are emerging, and how hiring practices are evolving.
The FDA is undergoing a major transformation in its drug approval processes, regulatory oversight and transparency initiatives. This webinar explores the implications of these reforms and what they mean for innovation, compliance and strategy in the biopharma industry.
This discussion focuses on how sequencing-based insights can power AI-driven design and data-driven validation, helping to develop safe and effective drugs for treating and preventing disease.
During this webinar BioSpace sits down with former FDA Chief Information Officer Vid Desai to discuss the potential advantages and pitfalls of deregulation stemming from one of President Donald Trump’s first executive orders. Together, they uncover what this shift means for drugmakers, compliance and patient safety.